The Life Science Effect

In late 2021, the COO, founder, and CEO of BPM Associates gathered to do their annual planning. They decided that they needed a new vision statement that would resonate with their core ideology. They watched Simon Sinek's TED Talk on starting with "why" and realized that people don't buy from BPM or work for BPM because of what they do, but because of why they do it. They decided to focus on doing business with those who believe in their "why", even if it meant walking away from some opportunities. They wanted to create a company that attracted outstanding people and provided top talent for life science projects.

We're back! In this trailer, Steve explains why it has been so long, how we can have a Season 2 when there wasn't really a Season 1, and what you can expect from this season of the show.

I've heard it said that culture beats strategy. I believe that. I also believe culture beats tactics and process and procedure and technique. In this episode (another solo episode), I will relate a recent story in which I had the chance to stand up and reinforce the safety culture of my client.

It may not be for everybody. It may not be "life science" specific. That's okay. Not to worry. Life Science talk returns next time and guests return late summer or early fall this year. Thanks for your support!

Thanks to our sponsor BPM Associates - www.bpm-associates.com

What Does It Take To Succeed As A Bioentrepreneur? Source: Life Science Leader By Karl Schmieder

Steve continues the discussion of how to transition into the startup world. The context is an article from a while back that still has relevant lessons for today.

Also referenced in this episode:

EP. 455 — RICH KARLGAARD Maybe You're a Late Bloomer. It’s More Possible Than Ever Now to Flourish Later in Life

Good to Great: Why Some Companies Make the Leap...And Others Don't Kindle Edition by Jim Collins

Steve is solo this week. He decided to give his thoughts about an article in Life Science Leader - From Academia To Pharma CEO: Challenges and Lessons Learned by Graham Kelly

Be sure and visit our presenting sponsor:

BPM Associates

What if a cutting edge technology saved your life? And then what if you got to be part of a startup company that is working on similar technology to save others' lives? Karen Momper, of Theratome Bio is living that story.

This week, Micheal Coleman, PhD, and Karen tell the story of Theratorm Bio and the exciting platform they are working on. Learn about how Theratome Bio is developing a portfolio of products derived from adult stem cell secretions. The future includes exciting potential therapies like stroke treatment and organ preservation during transport.

Learn Michael's and Karen's inspiring stories.

Resources in this episode:

Indiana Center for Biomedical Innovation

TheratomeBio.com

Theratome Bio on LinkedIn

Theratome Bio on Facebook

About Michael Coleman, PhD: Michael brings a wealth of research and new drug development experience to Theratome Bio.  He directed multidisciplinary teams at GeneMedicine and Valentis in Houston, Texas, prior to accepting a role with Centelion (a subsidiary of Sanofi-Aventis) as Vice President of R&D.   He there led a team of scientists in discovery, process & clinical development, and regulatory affairs.  Most recently, Michael was President and CEO of InGeneron, a medical device firm committed to driving personal regenerative medicine therapies.  During his tenure InGeneron attained several regulatory approvals in Europe and initiated clinical trials in the US under FDA approval.

Michael has dedicated his career to developing new therapies, ushering these innovations through regulatory paths, and ultimately seeing new therapies transitioned into the clinic.  He has also continued to publish research in peer-reviewed journals and maintain a close relationship with leading researchers and clinicians in academia.

He earned his BS and MS degrees from Texas A&M, his PhD from Penn State, and completed post-doctoral work at the Baylor College of Medicine.

Michael has a passion for the regenerative medicine space.  He’s long thought that a cell-free option is where the future of regenerative therapy is headed, and believes that TheratomeTM technology provides the key attributes of product consistency and ease of handling and administration necessary to achieve widespread clinical application.  In his own words, “TheratomeTM technology solves the key issues limiting clinical application of stem cell based therapies.   I am excited for the opportunity to be part of developing this technology that will provide life changing benefits patients and disrupt the field of regenerative medicine.”

Karen earned a B.A. in Chemistry with a minor in Marketing from the University of Dayton.  She completed an Undergraduate Thesis while there, worked for the Office of Admission leading campus tours, and was hired as a new grad to work as a Traveling Student Recruiter.

Karen began her career with the Bristol-Myers Squibb Company shortly thereafter.  During her ten years of employment, she served Primary Care and Hospital Sales roles, sold in multiple outpatient and inpatient therapeutic areas, negotiated formulary contracts, earned district, region, and national recognition for sales, and was selected to serve in leadership roles within her district.

Since then, Karen has taken on several non-profit initiatives whereby she has initiated a group, raised funding, and marketed and maintained a leadership role in organizations. She has also used her public speaking abilities to fund-raise.  In one such effort, she contributed to the establishment of an in-house Therapeutic Massage Therapy Program to treat Oncology Patients at Oregon Health and Science University (OHSU) Hospital in Portland, Oregon, a cause that was previously only filled by intermittent volunteers.

Karen is happily married, and proud mother to two sons. In addition to multiple volunteer roles at her Parish and children’s schools, Karen reads live broadcasts for IRIS Radio, a free service that provides audio news and literature for the visually impaired.  Karen is also the survivor of a stem cell transplant (2009), and an autologous stem cell procedure to her hip to reduce the likelihood for need of replacement. These experiences fuel her unique passion for furthering regenerative medicine innovation.

If you have not already done so, check out Beyond the Stethoscope - Angela Demaree's wonderful podcast for veterinarians, healthcare providers and busy professionals who want actionable, implementable solutions surrounding work-life balance, accomplishing your goals and living your dreams.

Angela does a great job of interviewing Steve Vinson in this cross-cast episode of The Life Science Effect.

Resources mentioned in this episode:

Indiana Health Industry Forum, https://ihif.org/

Indiana Biosciences Research Institute, https://www.indianabiosciences.org/

Inside Indiana Business, Life Science Newsletter http://www.insideindianabusiness.com/category/301752/life-sciences

The Life Science Leader https://www.lifescienceleader.com/

Connect with Steve on Linked In https://www.linkedin.com/in/stevenvinson/

and Twitter  https://twitter.com/steve_vinson 

[email protected]

This is Part 2 of a two part conversation with Kyle Keeney, Entrepreneur-In-Residence, Elevate Ventures.

In Part 1, Kyle told the story of bringing his experience on the coasts, in Europe, and around the world back home to boost the economy in Southern Indiana/Northern Kentucky.

In part 2, Kyle describes how important it is for communities to take a long view when it comes to securing the future of innovation and sciences. Then, Kyle and Steve discuss some of their favorite books. Kyle tells Steve how he fosters a love of reading and learning in his children.

An experienced Chief Executive Officer with a demonstrated record of success in supporting innovation in life science and think tanks, Kyle offers the skills to build meaningful partnerships and relationships that cross boundaries to move science-based discoveries forward. With his business development skills and a focus on entrepreneurship, Kyle establishes novel collaborations, and fosters the commercialization of new technologies and ideas.

A proactive leader, Kyle encourages collaboration and communication, which serves as the foundation for bringing new ideas to fruition. He always seeks the opportunity to build new bridges as the means to fostering paths that lead to the emergence of capabilities in the sciences.

Resources mentioned in this episode:

https://www.ynharari.com/book/sapiens/

https://www.ynharari.com/book/21-lessons/

http://www.jareddiamond.org/Jared_Diamond/Guns,_Germs,_and_Steel.html

http://www.jareddiamond.org/Jared_Diamond/Collapse.html

https://www.goodreads.com/book/show/146153.What_Are_People_For_

https://www.simonandschuster.com/books/The-Tangled-Tree/David-Quammen/9781476776620

https://www.elevateventures.com/

http://communities.techstars.com/usa/indianapolis-in-usa/about

This is Part 1 of a two part conversation with Kyle Keeney, Entrepreneur-In-Residence, Elevate Ventures.

In Part 1, Kyle tells the story of bringing his experience on the coasts, in Europe, and around the world back home to boost the economy in Southern Indiana/Northern Kentucky.

How can entrepreneurs tap into the capital resources available for startups? Where can they get objective advice on how to attract and use the right resources? And, importantly, what's it all for? Kyle is a devoted family man and an active member of his community.

An experienced Chief Executive Officer with a demonstrated record of success in supporting innovation in life science and think tanks, I offer the skills to build meaningful partnerships and relationships that cross boundaries to move science-based discoveries forward. With my business development skills and a focus on entrepreneurship, I establish novel collaborations, and foster the commercialization of new technologies and ideas.

A proactive leader, I encourage collaboration and communication, which serves as the foundation for bringing new ideas to fruition. I always seek the opportunity to build new bridges as the means to fostering paths that lead to the emergence of capabilities in the sciences.

Part 2 will be a more personal discussion about books and the importance of inspiring kids to read.

Resources mentioned in this episode:

https://www.elevateventures.com/

http://communities.techstars.com/usa/indianapolis-in-usa/about

16 Tech is the future of collaboration in downtown Indianapolis. It will bring together the talent, capital, and technology to make innovation happen.

Robert Coy is President and CEO of 16 Tech Community Corporation Inc., the entity overseeing the development of the 16 Tech innovation community. As President, Coy leads the development of 16 Tech into a major hub for scientific research, technology innovation, entrepreneurial activity and talent development, retention and attraction.Prior to 16 Tech, Coy was President and CEO of CincyTech, a venture development organization that accelerated the growth of start-up bioscience, healthcare, technology and advanced manufacturing companies in Southwest Ohio. Under Coy’s leadership for more than 11 years, CincyTech invested in 70 startups that raised more than $680 million in seed, early and late stage capital and that today employ nearly 1,000 people.Coy has held entrepreneurial and economic development leadership positions with public and private institutions over the past 32 years in Ohio, Missouri, Delaware and Pennsylvania.Prior to joining CincyTech, Coy was senior vice president for entrepreneurial development and of economic development at the St. Louis Regional Chamber and Growth Association, where he co-founded the St. Louis Arch Angels, a group of individuals who invest in early-stage companies in the St. Louis region.In Delaware, Coy served as the principal economic adviser to the governor, established a seed fund to invest in technology start-up companies and developed initiatives to promote technology partnerships between universities and businesses. In Pennsylvania, he served as executive director of the Ben Franklin Partnership Program, the state’s premier technology development program that invests in start-up companies.Coy earned a master’s degree from University of Notre Dame and a bachelor of arts degree from Pennsylvania State University.